Skip to main content
. 2020 Aug;9(4):1112–1123. doi: 10.21037/tlcr-19-577

Figure S3.

Figure S3

The Benefit Analysis of adjuvant chemotherapy (ACT) in All Patients with Stage IB Adenocarcinoma. These patients showed no survival difference between with and without ACT.